Nyse american to suspend trading in navidea biopharmaceuticals, inc. (navb)

New york--(business wire)--nyse american llc (“nyse american” or the “exchange”) announced today that the staff of nyse regulation has determined to suspend trading in the common stock of navidea biopharmaceuticals, inc. (the “company”) — ticker symbol navb — from the nyse american. the staff suspended trading in the company's common stock because the listings qualifications panel (the “panel”) of the committee for review of the board of directors of the exchange (the “committee”) had issued a.
NAVB Ratings Summary
NAVB Quant Ranking